Matthew L. Sherman - 04 Oct 2021 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role
EVP & Chief Medical Officer
Signature
/s/ Jeffrey Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Oct 2021
Net transactions value
-$88,199
Form type
4
Filing time
06 Oct 2021, 16:00:18 UTC
Previous filing
29 Jun 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $88,199 -2,659 -5.5% $33.17 46,029 04 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.
F2 Includes 302 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2021.